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PI3K-AKTPlease cite this article as: Tirinato L
Colorectal Cancer Stem Cells, Genestransformation exists, although the effects of nutrients, primarily glucose, on the CSC behavior
are still mostly unexplored. Glucose is an essential fuel for cancer cells, and the connections
with LDs in the healthy and CSC populations merit to be more deeply investigated. Here, we
showed that a high glucose concentration activated the PI3K/AKT pathway and increased
the expression of CD133 and CD44v6 CSC markers. Additionally, glucose was responsible for
the increased amount of Reactive Oxygen Species (ROS) and LDs in both healthy and CR-CSC
samples. We also investigated the gene modulations following the HG treatment and found
out that the healthy cell gene profile was the most affected. Lastly, Atorvastatin, a lipid-
lowering drug, induced the highest mortality on CR-CSCs without affecting the healthy coun-
terpart.
Copyright ª 2019, Chongqing Medical University. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
The World Health Organization (WHO) guidelines recom-
mend limiting the daily free sugar intake for children and
adult at, if not lower, 10% of the total energy intake.1
Despite being key sources of carbon and energy for
cellular metabolism, epidemiological studies demonstrated
that the excess of sugars, especially glucose, in diet leads
to obesity,2 higher risk of heart diseases3 and diabetes,
including several related conditions, such as inflammation,
high blood pressure and insulin resistance.4 Moreover, some
studies report that an indirect link exists between sugar-
related diseases and an increasing risk of cancer.5,6 How-
ever, in 2012 the European Prospective Investigation into
Cancer and Nutrition (EPIC) study has instead shown a
direct correlation between high dietary sugar intake and a
higher risk of developing cancer.7
The exact mechanisms by which glucose might favor
cancer development are currently not fully understood.
Nowadays, glucose and lipid metabolic alterations have
been proposed as hallmarks of cancer, since several studies
are highlighting their involvement in malignant trans-
formation and cancer growth.8,9 Glucose is considered an
essential nutrient for cells, especially for cancer cells in
which the aerobic glycolysis is believed to be the favorite
pathway for producing ATP (the Warburg effect) to sustain
rapid growth.5 However, recent reports demonstrated that
cancer cells can also rely on the tricarboxylic acid (TCA)
cycle, which produces larger amounts of ATP through the
oxidative phosphorylation (OXPHOS) and biosynthetic pre-
cursors of amino acids, lipids and nucleotides.10 Glucose
metabolism produces ROS,6 and high glucose (HG) concen-
trations can induce de novo lipogenesis with free fatty acid
(FA) and triacylglycerol (TAG) production.11
Oxidative stress is considered one of the leading players
in altered metabolic pathways. Healthy cells in normal
conditions counteract oxidative stress by activating pro-
tective responses that can be not sufficient in stress con-
ditions. Compelling evidence suggests that a pro-oxidant
status might lead to inflammatory processes and conse-
quently to diseases, such as diabetes and cancer.12
Indeed, different types of cancer cells display high levels
of oxidative stress, which seem to favor cancer cellet al., ROS and Lipid Droplet acc
& Diseases, https://doi.org/10.1proliferation and migration, as well as resistance to
treatments.13
Deregulated lipid metabolism in cancer includes the
ability of malignant cells to preferentially synthesize and
use the endogenous sources coupled with more efficient
mechanisms to uptake the extracellular lipids.14 This
behavior translates into a high rate of lipid metabolism
that has been linked to carcinogenesis and metastasis.9,15
In particular, increased LD accumulation seem to be a
common feature of several cancers, including colorectal
cancer (CRC), where they are thought to act also as pro-
tective organelles against the toxicity due to excess of
ROS and free lipids, energy suppliers and sites for syn-
thesis of inflammatory mediators, thus favoring cell sur-
vival, aggressiveness and resistance to treatments.16e22 In
this context, a small subpopulation of cells inside the
tumor mass, called Cancer Stem Cells (CSCs), is consid-
ered to be the responsible for tumor initiation and pro-
gression, chemo- and radio-resistance, relapse and
metastasis.23 Therefore, LDs could participate in deter-
mining CSC features. Indeed, in some tumors, CSCs have
been shown to have higher LD content and, recently, LDs
have been proposed as a new functional marker in CR-
CSCs.24
The mechanisms behind such metabolic alterations in
healthy and cancer tissues are the subject of intense study.
Several oncogenic pathways result altered and, among
them, the PI3/AKT/mTOR signaling cascade is one of the
most investigated.25
Collectively, these observations point out to an
intriguing yet complex role of metabolic alterations in
linking diabetes and obesity with cancer. Nevertheless, the
effects of HG conditions on CSCs largely remain unex-
plored, while wider knowledge has been gained in the
healthy counterpart. Based on these considerations, the
present study aimed at investigating the responses to HG of
healthy colon cells (HCCs) and CR-CSCs, in comparison with
a normal glucose (NG) exposure. In particular, in our culture
conditions, modulations of stemness markers and PI3/AKT
protein expression were observed in CR-CSCs. Furthermore,
HG triggered ROS increase and LD accumulation, as well as
activation of genes related to lipid metabolism and
tumorigenesis, more largely in HCCs than in CR-CSCs.umulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
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+ MODELFinally, in an attempt to interfere with lipid synthesis
pathways, the use of Atorvastatin alone in NG and HG or in
combination with DGAT2 inhibitor (interfering with
cholesterol and TAG synthesis respectively) in NG reduced
significantly cell viability in comparison with Oxaliplatin, a
conventional chemotherapy drug used for treating CRC.
The present study may provide important implications in
the study of glucose-related diseases, including diabetes
and obesity, and contribute to our understanding of the
initiation and maintenance processes in glucose-linked
cancers.Materials and methods
Ethics approval and consent to participate
All study procedures were approved by the Institutional
Review Board of University of Palermo and King Abdullah
University of Science and Technology. Cancer tissues were
taken after written informed consent has been obtained.
All research was performed in accordance with relevant
guidelines and regulations.Cell cultures
CCD841 CoN epithelial colon cells (HCCs) (ATCC CRL-1790)
were cultured in Eagle’s Minimum Essential Medium (ATCC;
#30-2003) supplemented with 10% fetal bovine serum (FBS)
(ATCC; 30-2020) and 1% (v/v) penicillin/streptomycin
(Gibco; #15140122) in TC-treated flasks (Corning, Lowell,
MA) and passaged using 1X Tryple Express Enzyme (Thermo
Fisher Scientific; #12604039).
Colorectal cancer (CRC) tissues were obtained
following surgical resection, under the ethical standards of
the institutional committee of the University of Palermo.
Cancer specimens were mechanically and enzymatically
digested using collagenase and hyaluronidase shaking for 1
hour at 37 C. Digests were cultured in ultralow adhesion
flasks (Corning; #CLS3815) to enrich the cell culture in
CSCs, with a serum-free Advanced DMEM/F12 medium
(Thermo Fisher Scientific; #12634010), supplemented with
10 mM HEPES (Gibco; #15630080), 1 mM N-acetyl-L-
cysteine (Sigma Aldrich; #A9165), 1X N2 supplement
(Thermo Fisher Scientific; #17502048), 1X B-27 (Thermo
Fisher Scientific; #12587010), 10 mM Nicotinamide (Sigma
Aldrich; #N0636); 20 ng/mL of recombinant human
Epidermal Growth Factor (EGF) and 10 ng/mL of human
recombinant basic Fibroblast Growth Factor (bFGF) (both
from Peprotech; #AF-100-15 and #100-18C, respectively).
Following isolation protocol, we evaluated the expression
of CD133/CD44v6/CD166 CSC markers by FACS.26 Each CR-
CSC line has been used to test its tumorigenic potential by
subcutaneously injecting them into NOD/SCID mice. Cells
were maintained at 37 C in a 5% CO2 humidified incu-
bator. Cancer spheroids were expanded in vitro for several
passages, by enzymatic and mechanical dissociation.
Cancer spheroids grown under these culture conditions
were routinely screened by FACS for the expression of CR-
CSC markers.27,28Please cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1Glucose supplementation
For the normal glucose (NG) condition, cells were cultured
in their own complete media without adding D-Glucose
(glucose) (Gibco; #A2494001), while, in order to mimic a
very high glucose condition, cells were maintained in their
media supplemented with a final concentration of 50 mM
glucose (HG) for 72 hrs.
CR-CSC marker analysis
Cells were dissociated, harvested, washed twice in Phos-
phate Buffer Solution (PBS) 1X (Thermo Fisher Scientific;
#10010023) and stained with conjugated antibodies
CD44v6-APC (2F10, mouse IgG1) (R&D systems; #FAB3660A),
CD133/2-APC (293C3-APC) (Miltenyi Biotec; #130-090-854),
or corresponding isotype-matched control (IMC) CD3e-APC
(UCHT1, mouse IgG1) (R&D systems; #FAB100A). Stained
cells were analyzed using the Accuri C6 (Becton Dickinson)
flow cytometer. Analysis of protein expression levels was
performed using FlowJo software (ver. 10).
Western blot
Protein lysates of glucose-treated and euntreated CR-CSCs
were obtained by treating cells with ice-cold buffer con-
taining 10 mM Tris-HCl (Sigma Aldrich; #10812846001),
50 mM NaCl (Sigma Aldrich, #S3014), 30 mM sodium pyru-
vate (Sigma Aldrich; #P8574), 50 nM NaF (Sigma Aldrich;
#215309), 5 mM ZnCl2 (Sigma Aldrich; #229997), 1%Triton
(Bio-Rad; #1610407), protease inhibitor cocktail (Sigma
Aldrich; #P8340), phosphatase inhibitor cocktail 2 and 3
(Sigma Aldrich; #P5726 and #P0044 respectively), 0.1 nM
sodium orthovanadate (Sigma Aldrich; #450243), 10 mM
sodium butyrate (Sigma Aldrich; #B5887) and 1 mM PMSF
(Sigma Aldrich; #93482). Proteins were then loaded in a
SDS-PAGE gel and blotted on a nitrocellulose membrane.
Membranes were exposed to a blocking solution made by
PBS 0.1% Tween 20 (Sigma Aldrich; #P1379) and 5% non-fat
dry milk (Sigma Aldrich; #M7409) for 1 hour at room tem-
perature, and then incubated overnight at 4 C with pri-
mary antibodies specific for PI3K p110a (C73F8, rabbit IgG)
(Cell Signaling Technologies; #4249), phospho-AKT (Ser473)
XP (D9E, rabbit, IgG) (Cell Signaling Technologies; #4060),
AKT (rabbit polyclonal) (Cell Signaling Technologies;
#9272). b-actin (8H10D10, mouse) (Cell Signaling Technol-
ogies; #3700) was used as loading control. Primary anti-
bodies were detected by incubating the membranes with
secondary antibodies, anti-mouse or anti-rabbit, HRP-con-
jugated (goat H þ L) (Thermo Fisher Scientific) for 1 hour at
room temperature. Luminescence signal was revealed using
SuperSignal West Dura Extended Duration Substrate
(Thermo Fisher Scientific) and Amersham imager 600 (GE
Healthcare). Protein levels were calculated by densito-
metric analysis using ImageJ software.
ROS and LD quantification
Intracellular general ROS content was measured by using
freshly prepared chloromethyl-dichlorodihydrofluorescein
diacetate (CM-H2DCFDA) (Thermo Fisher Scientific;umulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
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+ MODEL#C6827) dye resuspended in anhydrous Dimethyl Sulfoxide
(DMSO) (Thermo Fisher Scientific; #D12345) according to
manufacturer’s instructions. LD content was assessed by
staining with LD540.24106 cells were seeded in T75 flasks
with or without 50 mM glucose and analyzed after 72 hours
(hrs). After treatment, HCCs and CR-CSCs were centri-
fuged, resuspended in PBS 1X and counted using a Bu¨rker
counting chamber (BLAUBRAND) by trypan blue (Thermo
Fisher Scientific; #15250061) exclusion method. Then,
5  105 live cells were incubated either with 3.5 mM CM-
H2DCFDA in pre-warmed Hanks’ balanced salt solution
(HBSS) (Thermo Fisher Scientific; #14025050) for 20 minutes
(min) at 37 C or 1:5000 LD540 in PBS 1X for 10 min at room
temperature, in the dark. After washing with PBS 1X, cells
were acquired on a FACSCanto II flow cytometer (BD Bio-
sciences) using a 488 nm laser for the excitation of both
dyes. The median fluorescence intensity was analyzed using
FlowJo software (ver. 10).
Confocal microscopy
To image LDs after 72 hrs of HG treatment, HCCs and CR-
CSCs were stained with LD540 1:5000 in PBS 1X for 10 min in
the dark and, after 3 washes in PBS 1X, nuclei were coun-
terstained with NucBlue Live ReadyProbes Reagent
(Thermo Fisher Scientific; #R37605) and, immediately
imaged under the microscope. Fluorescence images were
collected with both a Zeiss LSM710 and a Leica SP5
confocal-laser-scanning microscopies, equipped with a 63X
i-Plan Apochromat (numerical aperture 1.40) and a 63X HCX
PL APO (numerical aperture 1.4) oil immersion objectives,
respectively.
The Avizo 9.3 image reconstruction software was used
for processing the confocal image stacks. Avizo’s Noise
Reduction Median algorithms were applied for background
noise reduction. Feature extraction and reconstruction
(nuclei, LDs and cell membranes) were performed with
semi-automated image segmentation.
RNA extraction and Real-Time qPCR
After 72 hrs in NG or HG, 106 HCCs or CR-CSCs were pro-
cessed to extract total RNA using the High Pure RNA isola-
tion kit (Roche; #11828665001) and 1 mg RNA was retro-
transcribed in cDNAs by means of the RT2 First Strand Kit
(Qiagen; #330404), according to the manufacturer’s in-
structions, in a C1000 Touch Thermal Cycler (Bio-Rad).
After that, cDNAs were mixed with RT2 SYBR Green qPCR
Mastermixes (Qiagen; #330529) and aliquoted into 96-well
RT2 Profiler PCR Arrays (Qiagen), for the simultaneous
detection of gene panels related to Fatty Acid Metabolism
(#PAHS-007Z), Lipoprotein Signaling and Cholesterol Meta-
bolism (#PAHS-080Z), Oxidative Stress (#PAHS-065Z) and
Oncogenes and Tumor Suppressor Genes (#PAHS-502Z), in a
ABI 7900HT Real-Time PCR System (RT-qPCR) (Thermo
Fisher Scientific). Data analysis of triplicated plates was
performed using the software available at the Data Analysis
Center (http://www.qiagen.com/geneglobe, Qiagen) and a
2-fold change was chosen as a cut-off. Normalization of CTPlease cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1values was done on b-actin (housekeeping gene) expression
and 2^(-DDCT) method was used to calculate the fold
changes of treated (HG) versus untreated (NG) samples.
Drug treatments and propidium iodide staining
HCCs and CR-CSCs were seeded (3  105 cells/well) in 24-
well plates (Corning; #CLS3527) in NG media for 24, 48
and 72 hrs, supplemented with either Oxaliplatin (Sigma
Aldrich; #O9512) or Atorvastatin (Sigma Aldrich; #PZ0001)
or PF-06424439 (Sigma Aldrich; #PZ0233), used singularly
(for HCCs and CR-CSCs) or in double combination (only for
CR-CSCs). Moreover, CR-CSCs were also treated with the
same drugs in HG for the same time points. Subsequently,
cells were collected and stained with 2 mg/mL Propidium
Iodide (PI) (Sigma Aldrich; #P4864) in PBS 1X soon before
the acquisition at the FACSCanto II cytometer, by using an
excitation of 488 nm.
Statistical analysis
Survival results presented in the Fig. 7 were obtained using
the “R2: Genomics Analysis and Visualization Platform
(http://r2.amc.nl, http://r2platform.com)” and analyzed
with a log-rank (ManteleCox) test and expressed as
KaplaneMeier survival curves.
All data have been run in triplicates and are expressed as
means  SD. Statistical analyses have been performed by t-
test or One-way ANOVA as indicated in the figure legends.
Statistical significance was indicated as follow: p  0.05 (*),
p  0.01 (**) and p  0.001 (***). Only values with a sig-
nificance 0.05 have been taken into consideration.
Results
CSC markers are upregulated by high glucose
concentration
Four different CR-CSC cell lines, which grew in vitro as
tumor organoids (Fig. 1a), have been cultured for 72 hrs in
NG or HG concentration. We have previously demonstrated
that CD133 is a cell surface molecule specifically expressed
on CR-CSCs,29 and that activation of PI3K/Akt pathway la-
bels the metastatic CR-CSCs, identified for the expression
of CD44v6.27 Thus, to investigate the contribution of
glucose in the regulation of cancer stemness, at the end of
the incubation, CR-CSCs have been analyzed for the PI3K-
AKT pathway activation and for the expression of CD133
and CD44v6, by Western blot and FACS, respectively. Our
results showed that a 72 hrs time exposure to HG concen-
tration was sufficient to hyperactivate the PI3K pathway, as
demonstrated by the upregulated phosphorylation of AKT
(p-AKT) (Fig. 1b). Given the role of PI3K/AKT pathway in
cancer,30 these findings suggested a putative role of glucose
metabolism in the regulation of several aspects of CR-CSC
behavior, including proliferation and survival. To ascertain
the correlation between the activation of PI3K/AKT
pathway and the establishment of a CSC phenotype, weumulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
Figure 1 72 hrs in HG cell culture medium is sufficient to increase CSC markers in CR-CSCs. a) Primary CR-CSC spheroids
(#1, #4, #8 and #9) were cultured in ultra-low adhesion flasks and morphology was assessed by phase-contrast microscopy (scale
bar: 1000 mm). b) Fold variation of protein expression in CR-CSCs treated with HG versus NG. Data are representative of 3 inde-
pendent experiments performed with cells derived from 3 different CR-CSC lines. c) Representative Western blot of PI3K, phos-
phorylated (p-AKT) and total AKT in CR-CSC treated with HG or NG (#9 CR-CSC line is shown). b-Actin has been used as loading
control. The uncropped blots are reported in Supplementary Fig. 1. d) Fold variation of positivity for CD133 or CD44v6 in CR-CSCs
treated as in (b and c), measured by FACS.
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markers in all CSC lines, upon HG treatment. Interestingly,
cells treated with HG medium showed significantly higher
expression of CD133 (#4), CD44v6 (#1 and #8), or both cell
surface markers (#9), compared to cells grown in control
medium (Fig. 1c). In light of these results, we could spec-
ulate that constant and prolonged exposure to an increased
amount of glucose in tumor context could dramatically
affect cancer cell proliferation.
High glucose concentration increases the amount of
lipid droplets and ROS
To assess whether HG induced oxidative status modifica-
tion, HCCs and CR-CSCs were cultured in NG or HG media
for 72 hrs. Fig. 2a shows that HG conditions induced a
statistically significant increase of ROS both in HCCs and CR-
CSCs, as assessed by using CM-H2DCFDA probe, a general
oxidative stress indicator. In particular, HCCs showed
approximately 40% (Fig. 2a left side) and CR-CSCs 12%Please cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1(Fig. 2a right side) increase in ROS, as compared with the
respective controls.
Furthermore, the effect of HG condition on the LD
modulation was also investigated. As shown in Figure 2,
72 hrs of 50 mM glucose treatment induced LD accumula-
tion in HCCs (almost 30%) (Fig. 2b left side) and at a minor
extent, but still significant, in CR-CSCs (9%) (Fig. 2b right
side). Qualitative LD increase was also observed by
confocal microscope and a 3D reconstruction of both NG
and HG samples is exemplified in Fig. 2c.
Glucose effects on fatty acid metabolism
To understand the gene alterations behind the LD modu-
lation, we decided to study the gene expression changes
related to the FA metabolism. In HCCs, the most up-
regulated genes were HMGCS2 (fold regulation
(fr) Z 5.42), involved in ketone body metabolism.
Increased gene expression was also observed for ACSL6
(fr Z 3.74) and ACOT6 (fr Z 2.08), embroiled in FAumulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
Figure 2 ROS and LD comparison of HG versus NG conditions in both HCCs and CR-CSCs after 72 hrs from the beginning of the
treatment. a) HCCs and CR-CSCs were collected and stained with CM-H2DCFDA, as reported in the Material and Methods section
and analyzed by FACS. A higher increase in ROS was observed in HCCs compared to CR-CSCs. b) HCCs and CR-CSCs stained with
LD540 were analyzed by FACS. Both samples showed a LD increase in HG, with HCCs being more affected. c) 3D reconstruction of
both HCCs and CR-CSCs in NG and HG conditions stained with LD540 (green) for visualizing LDs and counterstained with NucBlue
(blue) for imaging nuclei. In the inset Max Intensity Projection of the relative z-stack images used for the 3D reconstruction. All
images were taken at the confocal microscopes, as reported in Materials and Methods (Section ROS and LD Quantification) and were
mounted with Avizo 9.3. Scale bar is 10 mm. Note: *p  0.05; **p  0.01; ***p  0.001.
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+ MODELmetabolism, GPD1 (fr Z 3.25), encoding for NAD-
dependent glycerol-3-phosphate dehydrogenase 1, and
FABP4 (fr Z 2.13), involved in FA transport. On the other
hand, DECR2 (fr Z 3.33), an auxiliary peroxisomal
enzyme involved in unsaturated FA-oxidation, was down-
regulated. In CR-CSCs, PRKAG3, one of the two regulatory
subunits of the AMPK, was up-regulated (fr Z 3.44) and it
was the only gene showing modulation after 72 hrs of HG
treatment. Figs. 3e6.
Thus, HG seemed to have a bigger influence on FA
metabolism of HCCs than of CR-CSCs, as in the latter almost
all the genes analyzed did not exhibit high changes in
expression, as compared to NG.Please cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1Glucose effects on lipoprotein signaling and
cholesterol metabolism
To assess changes in genes involved in the major lipoprotein
signaling and cholesterol pathways in response to 72 hrs of
HG treatment, PCR Arrays were performed.
In HCCs, 50 mM glucose induced a strong up-regulation
of CELA3B (fr Z 22.7) and at less extent of APOL1
(fr Z 2.11) and CYP11A1 (fr Z 2.03), all involved in
cholesterol metabolism. Also, CYP7A1, a gene participating
in cholesterol catabolism, resulted up-regulated (frZ 6.4).
On the other hand, APOL5 (fr Z 3.94) and NR0B2umulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
Figure 3 RT2 Profiler PCR analysis of Human Fatty Acid Metabolism. a) Scatter plot of the 84 genes present in the array. Red
dots indicate up-regulated genes, while the green dot indicates the down-regulated gene, all compared to NG condition. The
central line shows genes that were unchanged with boundaries representing the two-fold regulation cut-off. b) Table reporting all
genes affected by the HG concentration in both HCCs and CR-CSCs with the respective fold regulations. Only fold regulations 2
and p-values  0.05 were considered.
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+ MODEL(fr Z 3.25), the former encoding for an intracellular
protein likely related with lipid movement and interaction
with organelles, the latter encoding for a nuclear repressor
(SHP) likely inhibiting steroid hormone pathway, were the
most down-regulated genes in HCCs. Negative fold regula-
tion was also observed for PCSK9 (fr Z 2.42), involved in
cholesterol homeostasis being able to control the activity of
low-density lipoprotein (LDL) receptors, and AKR1D1
(fr Z 2.3), which participates in cholesterol catabolism,
and STAB2 (fr Z 2.21), which encodes for a trans-
membrane receptor able to bind to LDLs. In CR-CSCs
instead, there was only one gene up-regulated, with a
highly positive fold regulation (fr Z 13.91), that was
APOA1, whose product is a high-density lipoprotein (HDL)-
associated protein with antioxidant activity, participating
in cholesterol homeostasis. Furthermore, a decrease in
expression was observed for CELA3A (fr Z 2.73), a gene
encoding for an elastase with a potential function inPlease cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1cholesterol metabolism. In summary, glucose treatment
affected the expression of a higher number of lipoprotein
signaling- and cholesterol metabolism-related genes in
HCCs than in CR-CSCs.Glucose effects on oxidative stress
ROS gene modulation was also investigated with the same
approach pursued for LDs. In HCCs, after glucose treatment,
up-regulationwas observed for TPO (frZ 4.79) geneencoding
for protein with antioxidant activity, as well as for NOS2
(fc Z 3.25), NOX5 (fc Z 3.13), ALOX12 (fr Z 2.66), mainly
involved in ROS metabolism. Instead in CR-CSCs, decreased
expression was reported for NCF1 (fr Z 4.36). Hence, HG
exposure induced only up-regulations of oxidative stress-
responsive genes in HCCs, and in CR-CSCs only down-
regulation of a gene involved in superoxide anion production.umulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
Figure 4 RT2 Profiler PCR analysis of Human Lipoprotein Signaling and Cholesterol Metabolism. a) Scatter plot of the 84 genes
present in the array. Red dots indicate up-regulated genes, while the green ones indicate the down-regulated genes. The central
line shows genes that were unchanged with boundaries representing the two-fold regulation cut-off. b) Table reporting all
genes affected by the HG concentration in both HCCs and CR-CSCs, as compared to NG conditions. Fold regulations 2 and p-values
 0.05 were considered.
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+ MODELGlucose effects on oncogenes and tumor
suppressor genes
When analyzed the expression of oncogenes and tumor
suppressors, HCCs showed only down-regulations, such as
for BCL2 (fr Z 2.23) and MYB (fr Z 4.45), considered
oncogenes, and RUX3 (fr Z 3.3), which is a tumor sup-
pressor gene. Instead, in CR-CSCs, HG treatment did not
elicit changes in the genes analyzed by the PCR Array,
suggesting that in cancerous cells HG did not strongly affectPlease cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1the expression of genes whose behavior could be already
altered.
Dysregulation of lipid metabolism and oxidative
stress pathways drives CRC progression
Despite the fact that the prognostic impact of high blood
sugar levels on CRC initiation and progression has been an
unexplored topic for a long time, recent studies have
demonstrated that hyperglycemia is involved in severalumulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
Figure 5 RT2 Profiler PCR analysis of Human Oxidative Stress. a) Scatter plot of the 84 genes present in the array. Red dots
indicate up-regulated genes, while the green one indicates the only down-regulated gene. The central line shows genes that were
unchanged with boundaries representing the two-fold regulation cut-off. b) Table reporting all genes affected by the HG con-
centration in both HCCs and CR-CSCs, as compared to NG conditions. Only fold regulations 2 and a p-values  0.05 were
considered.
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gression,32 with the regulation of crucial phenomenons
underlying CRC patients survival. On this regard, the
acquisition of a mesenchymal/invasive phenotype33 and the
acquired chemoresistance are fundamental for CRC pa-
tients prognosis.34 Given that CSCs are considered to drive
all the above-mentioned steps of tumorigenesis, we
decided to investigate the clinical impact of the differen-
tially expressed genes of CR-CSCs upon treatment with HG.
Importantly, our data indicate that higher expression levels
of PRKAG3 and APOA1 which were upregulated upon HG cell
culture conditions, significantly correlate with a worse
prognosis for CRC patients, as indicated by the Kaplan Meier
showing the relapse free survival (RFS) probability (Fig. 7).
Differently, high expression levels of CELA3A and NCF1,
that were downregulated following HG treatment, show a
significant association with better survival rates (Fig. 7).Please cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1Drug treatments
Since an increase of the LD amount was observed in both
cell lines grown in glucose enriched media, HCC and CR-CSC
mortality was analyzed upon treatment with two drugs
interfering with lipid metabolism, namely Atorvastatin
(10 mM) and PF-06424439 (10 mM). In particular, Atorvastatin
works inhibiting the 3-hydroxymethyl-3-glutaryl (HMG)-co-
enzyme A (CoA) reductase (HMGCR) to competitively block
the conversion of HMG-CoA to mevalonate, which is a pre-
cursor in the synthesis of cholesterol.35 It is usually used to
treat dyslipidemia that can also occur in type 2 diabetes
mellitus. Instead, PF-06424439 is an inhibitor of the diac-
ylglycerol acyltransferase 2 (DGAT2) enzyme, which cata-
lyzes the final step in the synthesis of TAGs, thus likely
impairing FA synthesis and LD formation.36 Cell mortality
was also analyzed after 10 mM of Oxaliplatin treatment,umulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
Figure 6 RT2 Profiler PCR analysis of Human Oncogenes and Tumor Suppressor Genes. a) Scatter plot of the 84 genes present
in the array. Green dots indicate down-regulated genes. The central line indicates genes that were unchanged with boundaries
representing the two-fold regulation cut-off. b) Table reporting all genes affected by the HG concentration in both HCCs and CR-
CSCs, as compared to NG. Only fold regulations 2 and p-values  0.05 were considered.
10 L. Tirinato et al.
+ MODELchosen because it is a platinum-based chemotherapy agent
commonly used for treating CRC.37 Results from flow
cytometry analysis of dead cells after 24, 48 and 72 hrs of
drug treatments in NG are shown in Fig. 8. While in HCCs all
the tested drugs did not induce significant mortality over-
time (Fig. 8a), in CR-CSCs at 48 and 72 hrs both Oxaliplatin
(91% and 171%, respectively) and Atorvastatin (78% and
488%, respectively) increased cell mortality compared to
the untreated cells (Fig. 8b). By contrast, PF-06424439 did
not seem to have effects on cell death at each time point,
as compared to the controls (Fig. 8b).
To evaluate whether additional effects could be ob-
tained by combined use of drugs, CR-CSC mortality was
studied in NG media in a time course experiment (Fig. 8c).
All the double combinations resulted in a significant time-
dependent increase in cell mortality. Particularly, while
at 24 hrs the combined treatments did not result in strong
differences in cell death (30% for Oxaliplatin/PF-06424439;
58% for Oxaliplatin/Atorvastatin; 43% for Atorvastatin/PF-
06424439) compared to the control, at 48 hrs and much
more at 72 hrs huge effects were observed with Oxalipla-
tin/Atorvastatin (128% at 48 hrs and 517% at 72 hrs) and
Atorvastatin/PF-06424439 (230% at 48 hrs and 1000% at
72 hrs).
Thus, higher effects were exhibited by the combination
of Atorvastatin with PF-06424439 in the long run. Moreover,
under conditions of excessive glucose availability, the
highest impact on CR-CSC mortality was exerted byPlease cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1Atorvastatin, indicating that statin in combination with HG
could sensitize CR-CSCs to death especially after 72 hrs
(Fig. 8d).Discussion
LDs are nowadays well recognized as important players in
CRC development and stemness,24,38 and they have been
proposed as a new functional marker in CR-CSCs.24 More-
over, the desaturation level of lipids present inside LDs was
also suggested as a metabolic stem cell marker in ovarian
cancer.39
Recent shreds of evidence highlighted a possible role of
metabolic alterations in inducing malignant trans-
formation, and in this context, glucose and lipid metabo-
lisms and their interplay are currently areas of expanding
interests. It is still unclear to which extent a glucose excess
could affect cancer cells, in particular CSC stemness and
trigger the LD accumulation. Besides, few reports have in-
depth documented the effects of HG concentrations in non-
malignant colon cells.
Based on these considerations, in the present experi-
mental work, we studied the effects of 72 hrs exposure to
HG concentrations in healthy and in cancer stem cells. The
goal was to investigate the effects of an excess of glucose
that represents an extreme circumstance of pathological
conditions. Firstly, we found that in CR-CSCs HG elicitedumulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
Figure 7 Clinical impact of genes involved in lipid metabolism and oxidative stress. Relapse-free survival (RFS) rate of CRC
patients (Tumor Colon-Sieber database) according to PRKAG3, APOA1, CELA3A and NCF1 expression levels.
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+ MODELactivation of the PI3K/AKT pathway and a higher expression
of stemness markers (CD133 and CD44v6), associated with a
reduced growth (data not shown), thus pointing out the
importance of glucose as a crucial nutrient for CR-CSCs.
Also, this evidence suggested that glucose concentration in
the tumor microenvironment might significantly affect CSC
behavior and aggressiveness.
Secondly, a significant induction of ROS was observed
upon HG treatment in both cell lines. This observation was
in agreement with other studies showing an increase of ROS
in hyperglycemic conditions, presumably resulting from anPlease cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1overburdened mitochondrial electron transport chain or
hyperactivated enzymatic systems, including NOX and NOS
enzymes.40,41 Moreover, high ROS were also accompanied
by a simultaneous overproduction of LDs both in healthy
and CR-CSCs, which suggested that the excess of glucose
might be, at least in part, converted and stored as lipids
(cholesterol and triglycerides) in the form of LDs, as already
reported in literature.42,43 In healthy and cancer cells, LDs
might have a protective role against lipotoxicity, as well as
be an essential source of energy.44 However, the observed
ROS and LD over-loading following long-term glucoseumulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
Figure 8 Cell death analysis and comparison between Oxaliplatin, Atorvastatin and PF-06424439 in HCCs and CR-CSCs.
a) HCCs have been treated with Oxaliplatin 10 mM, Atorvastatin 10 mM or PF-06424439 10 mM for 72 hrs. Afterwards, cells were
collected, stained with PI and analyzed by FACS. b) CR-CSCs were treated as HCCs and stained with PI. c) The drugs were used in
double combinations in order to obtain a possible synergistic effect in killing CR-CSCs; d) single drug treatments (Oxaliplatin,
PF-06424439 and Atorvastatin, 10 mM all) were tested on CR-CSCs both in NG and HG. Note: *p  0.05; **p  0.01; ***p  0.001.
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+ MODELsupplementation might also impair cellular functions. In
fact, it has been well documented that high ROS levels
promoted inflammation and that their increase, following
excessive glucose intake, induced LD accumulation and
could lead to pathophysiological conditions, including dia-
betes, obesity, aging and cancer.45e47 It has also been re-
ported that increased ROS formation resulted in
peroxidized LD accumulation in glia and the two conditions
together could cause neurodegeneration.48 Thereby, regu-
lation of genes involved in oxidative stress, FA and choles-
terol metabolism was also evaluated after prolonged HG
exposure. Our qPCR array data revealed that, in response
to increased availability of glucose, HCCs mainly up-
regulated oxidative stress-responsive genes and superox-
ide metabolism genes. Notably, NOS2, NOX5 and ALO1X2
genes resulted increased, the former of which encodes for
an enzyme responsible for the production of nitric oxide
(NO), which, in addition to be a signaling molecule, is also
involved in inflammatory responses and, by interaction with
superoxide anion (O2$) can cause oxidative damages.49 In
fact, NOS2 overproduction can inhibit the mitochondrial
electron transport chain, induce DNA strand breaks and has
been associated with poor cancer prognosis.49,50 NOX5 en-
codes for a NADPH oxidase that generates O2$ and, like
for NOS2, its increased expression has been reported in
different type of cancers.51 Instead, ALOX 12 protein is a
lipoxygenase, which catalyzes the peroxidation ofPlease cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1polyunsaturated FA, thus producing bioactive lipids and
ROS, which in turn can stimulate inflammation and promote
oxidative stress.52 Interestingly, elevated expression of this
gene has been observed in pancreatic and brain cells in
response to hyperglycemia.53e55 Surprisingly, our data
highlighted a particular and unexpected Thyroid peroxidase
(TPO) overexpression in HG-treated HCCs. In fact, TPO is
typically expressed in the thyroid gland, however a recent
work has shown its expression also in the healthy and
cancerous breast tissues,56 while activated thyroid hor-
mones were increased in CR-CSCs in which induced differ-
entiation and sensitization of CR-CSCs.57 To date, we do not
know the role of TPO in the healthy colon cells under high
glucose conditions, but its ability to use hydrogen peroxide
might be involved. Further investigations to establish TPO
role and function in presence of excess of glucose are
needed and remain to be elucidated.
In our study, the over-activation of such oxidative stress-
related genes suggested for a potential effect of HG
exposure in promoting an inflammatory status in HCCs. As
far as the lipid metabolism is concerned, in HCCs we found
overexpression of genes encoding for enzymes in choles-
terol, FA and TAG metabolisms and lipid trafficking. On the
other hand, HCCs in the same culture conditions down-
regulated genes encoding mainly for a LDL receptor, LDL- or
HDL-associated proteins, as well as an enzyme in choles-
terol catabolism and an enzyme involved in FA b-oxidation.umulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
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+ MODELThese observations pointed out to modulation of intracel-
lular lipid accumulation and a reduction of circulating
cholesterol uptake. Of interest, FABP4, one of the up-
regulated genes in HCCs, has been proposed to be involved
in lipid transport to LDs for their storage that is in line with
our evidence of LD increased expression, as well as to
peroxisomes for oxidation.58,59 Studies also showed that its
up-regulation was correlated with the development of
inflammation, insulin resistance, diabetes mellitus and
obesity.58,60,61 Importantly, a recent work from Hao and
collaborators showed that elevated levels of circulating
FABP-4 were present in obese women with breast cancer. In
the same study, treatments with FABP-4 induced stemness
and aggressiveness of mammary cancer cells both in vitro
and in vivo, as well as tumor development, through IL-6/
STAT3/ALDH1 pathway, thus revealing a new link between
obesity and breast cancer.62 In light of these results, un-
derstanding if and how enhanced FABP-4 expression and LD
increase in hyperglycemic conditions might be linked and
involved in CR tumor development deserves further
investigations.
Interestingly, in HCCs a strong up-regulation was
observed for HMGCS2 gene, encoding for a rate-limiting
enzyme involved in the synthesis of ketone bodies, mostly
produced during starvation from the breakdown of FAs. This
finding suggested that HCCs might be capable of metabo-
lizing ketone bodies. In recent studies, it has been shown
that ketone bodies can support cancer growth in environ-
ments where the nutrient supply is limiting63,64 and
HMGCS2 has also been proposed as an apocrine cancer
biomarker.65,66 Here instead, we found its marked upregu-
lation in a HG enriched medium, where energy availability
should be not limiting. HMGCS2 is a mitochondrial enzyme,
so it may be possible that oxidative stress induced by HG
impairs mitochondrial functions that could account for this
observation. Taken together, these findings raise the pos-
sibility that very HG conditions might produce an excess of
FAs that, in turn, may be directed towards the storage, but
also to their activation and ketogenesis, despite HG avail-
ability. To date, the reasons for these responses remain to
be clarified, but they could be the expression of dysregu-
lated metabolic pathways activated/inhibited in HG con-
ditions. HCCs grown in HG for 72 hrs also showed decreased
expression of pro-apoptotic and tumor suppressor genes. As
an example, the oncosuppressor gene RUNX3 was down-
regulated in HG-treated HCCs. Reduced levels of its
expression have been associated with poor prognosis in
patients with CRC,67 and Runx3-null gastric cells showed
epithelialemesenchymal transition and tumorigenic stem
cell-like features.68 To our knowledge, here we reported
for the first time a relationship between hyperglycemia and
RUNX3-reduced mRNA levels that may provide a potential
link with tumorigenesis.
Conversely, in CR-CSCs, 72 hrs of HG treatment did not
seem to induce massive gene regulations. We noticed the
down-regulation of NCF1, the regulatory cytosolic subunit
of phagocytic NADPH oxidase complex. NCF1 in fact acti-
vates the complex, which subsequently produces O2, an
essential mechanism in immune system. Glucose excess
seemed to affect the regulatory mechanisms of the com-
plex that might induce lower superoxide production, even
though further studies are required, as currently NCF1 rolePlease cite this article as: Tirinato L et al., ROS and Lipid Droplet acc
Colorectal Cancer Stem Cells, Genes & Diseases, https://doi.org/10.1in non-phagocytic cells is poorly investigated and unex-
plored in CSCs.
Up-regulation was also found for PRKAG3 gene, which
encodes for an AMPK regulatory subunit which activates the
AMPK enzyme. Instead, the AMPK catalytic subunit gene
was not affected by HG exposure (data not shown). AMPK is
considered an energy sensor in the crosstalk between
multiple metabolic pathways and, when active, negatively
regulates the PI3K/AKT signaling cascade.69 Over activation
of the PI3K/AKT pathway, which promotes survival and
proliferation, is frequently associated with different types
of tumors, including CRC.27,70 Moreover, it has been docu-
mented that AKT signaling stimulates glucose uptake and
ATP production, indirectly hindering AMPK activation.71 In
the present study, we showed higher expression of PI3K and
AKT proteins in CR-CSCs under HG conditions, thus allowing
us to speculate that increased signaling activity of PI3K/
AKT pathway could inhibit AMPK and this could in somehow
correlate with the higher PRKAG3 mRNA levels observed in
HG. It is also noteworthy that AMPK inactivation stimulates
lipid synthesis72 suggesting a potential connection between
activated PI3/AKT cascade and LD accumulation seen after
long term HG exposure.73,74 Indeed, Vereshchagina et al.
showed that elevated activation of AKT in Drosophila nurse
cells induced to enlarged LDs and high expression of the fly
homologue perilipin.75
In our hyperglycemic conditions, APOA1 gene, respon-
sible for the expression of the main HDL-associated protein
which also participates in cholesterol efflux and reverse
transport, resulted strongly upregulated in CR-CSCs. It has
been recently showed that increased levels of APOA1/HDL
might protect against the onset of CRC,76 although the
mechanisms remain unfathomed. We also observed a sub-
stantial decrease in CELA3A mRNA in CR-CSCs. This gene
encodes for an elastase usually produced by pancreas with
digestive function and potentially able to bind cholesterol
even though its functional role in CRC remains to be
elucidated. However, better survival rates in patients were
associated with higher and lower expression levels of
APOA1 and CELA3A genes, respectively. Altogether these
observations raise the intriguing possibility that choles-
terol, whose esterified form is a component of LDs, might
play a crucial role in CR-CSC biology. A recent work from
Wang and colleagues highlighted a potential link between
an excess of cholesterol and increased growth of colonic
stem cells and, consequently, accelerated CRC develop-
ment.77 Thereby, the evidence of LD increase in CR-CSCs in
response to HG might be involved in processes linked to CR-
CSC survival in metabolic stress conditions. Thus, in the
present work, we tested the effects of Atorvastatin, a
commonly used statin inhibiting HMG-CoA reductase, on
cell viability when interfering with the cholesterol synthesis
pathway, and compared with PF-06424439, an inhibitor of
diacylglycerol acyltransferase (DGAT2) involved in the
synthesis of TAGs, and Oxaliplatin, a commonly used
chemotherapy drug for CRC.
In the last few years, both Atorvastatin and PF-06424439
have been largely studied as potential anti-cancer drugs,
and the molecular mechanisms involved in the lipid
pathway inhibition are well described elsewhere,78
although results from the literature are conflicting. Here,
we showed that Atorvastatin induced the highest mortalityumulation induced by high glucose exposure in healthy colon and
016/j.gendis.2019.09.010
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+ MODELon CR-CSCs after 72 hrs in NG, without affecting the healthy
counterpart. Noteworthy, when Atorvastatin was used in
combination with PF-06424439, a dramatic increase in cell
mortality was obtained after 72 hrs. This indicated that by
hindering both cholesterol and TAGs synthesis, synergistic
effects were markedly induced, as the PF-06424439 alone
was not able to kill cells at any time point. Then, when
analyzed the effect of Atorvastatin in the presence of HG,
CR-CSC mortality was increased compared to NG and, of
note, it was the only treatment able to exert this effect in
HG. Indeed, a recent paper from Sierra Gonzales and co-
workers has showed that supplementation with 25 mM
mannose, a derivative of glucose, reduced cancer cell
growth and, in combination with chemotherapy drugs,
made cells more sensitive to death in vitro and in vivo.79
Here we showed enhanced cell death in presence of
50 mM glucose and 10 mM Atorvastatin on the cancer stem
population. These preliminary findings suggested that sta-
tins may better interfere with CR-CSC growth in an
enriched glucose availability. Given the high FA and
cholesterol requirements of cancer cells for proliferation
together with the oxidative stress induced in response to
HG concentrations, the well documented dual (lipid-lowing
and antioxidant) effect of Atorvastatin80 could explain
these observations.
Conclusions
In conclusion, we demonstrated that 72 hrs of HG supple-
mentation was sufficient to increase ROS and to accumulate
LDs in both HCCs and CR-CSCs. In the latter population, HG
was also responsible for the increase of the stemness
markers and AKT activation, highlighting a tight correlation
between high tumorigenicity and LD generation. Moreover,
in our culture conditions, HG modulated transcription of
many genes related to FA metabolism, apolipoproteins
signaling, cholesterol metabolism, oxidative stress, onco-
genes and tumor suppressors, at a greater extent in HCCs
than in CR-CSCs.
Although the link between increased ROS and LDs and
enhanced risk of CR cancer in response to very HG condi-
tions warrants further investigations and more detailed
experiments are required in order to elucidate the under-
lying mechanistic links, our preliminary data provide useful
evidence to study the process involved in tumorigenesis and
cancer maintenance.
These results provide novel insights into the role of
glucose in metabolic alterations and might help to disclose
possible mechanisms for HG role in tumorigenesis. In
metabolic stress conditions LDs might work as a potential
functional marker not only in CR-CSCs, but also in the
healthy counterpart. In addition, our findings might be
useful to highlight potential targets of glucose or lipid
pathways for the therapeutic treatment of CRC and, in
particular, to eradicate CR-CSCs.
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